BIONTECH SE

BNTX

Delayed - 11/26 01:00:00 pm
348USD	+14.19%

Turn to zoom

Prev.	348.0000
Open	337.4300
High	372.4900
Low	335.0353
Volume	11 028 954

4h ago	BioNTech : will take two weeks to assess vaccine against latest Covid...
4h ago	BioNTech : Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY®...
6h ago	Novavax testing vaccine that targets new COVID-19 variant
7h ago	ADRs Close Lower; BioNTech Rises, Carnival Drops

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	353	447	389
Spread/Res.	-1,4%	-22%	-11%
Spread/Supp.	27%	71%	89%
Support	274	204	184

Sales 2021	17 474 M 19 776 M 19 776 M
Net income 2021	9 220 M 10 434 M 10 434 M
Net cash 2021	9 793 M 11 083 M 11 083 M
P/E ratio 2021	8,37x
Yield 2021	-

Capitalization	74 268 M 84 049 M 84 049 M
EV / Sales 2021	3,69x
EV / Sales 2022	3,18x
Nbr of Employees	2 800
Free-Float	87,3%

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...

>> Read more

Sector :

Bio Therapeutic Drugs

Calendar :

2021-11-30 Presentation

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	HOLD
Number of Analysts	15
Last Close Price	307,50 €
Average target price	259,68 €
Spread / Average Target	-15,6%